- Report
- January 2026
- 181 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- February 2026
- 250 Pages
Global
From €3986EUR$4,490USD£3,454GBP
- Report
- January 2026
- 281 Pages
Global
From €2219EUR$2,500USD£1,923GBP
- Report
- February 2026
- 160 Pages
Global
From €2947EUR$3,320USD£2,554GBP
€3684EUR$4,150USD£3,192GBP
- Report
- October 2025
- 160 Pages
Global
From €2981EUR$3,358USD£2,583GBP
€3507EUR$3,950USD£3,038GBP
- Report
- July 2025
- 150 Pages
Global
From €5282EUR$5,950USD£4,577GBP
- Report
- January 2026
- 181 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- January 2026
- 199 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- November 2025
- 188 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- August 2025
- 182 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- August 2025
- 186 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- August 2025
- 196 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- August 2025
- 182 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- August 2025
- 199 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- August 2025
- 186 Pages
Global
From €3147EUR$3,545USD£2,727GBP
€3497EUR$3,939USD£3,030GBP
- Report
- May 2026
- 270 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 340 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- January 2026
- 180 Pages
Global
From €3995EUR$4,500USD£3,461GBP
- Report
- January 2026
- 130 Pages
Global
From €4217EUR$4,750USD£3,654GBP
- Report
- December 2025
- 218 Pages
Global
From €4260EUR$4,799USD£3,691GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more